Orange Book product · Generic (ANDA)
NIMODIPINE
NIMODIPINE
At a glance
Apr 07, 2014
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 07, 2014
12 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
NIMODIPINE
Strength
30MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 090103
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NIMODIPINE
- 2013NYMALIZEBrand (NDA)
NDA 203340 · AZURITY
- 1988NIMOTOPBrand (NDA)
NDA 018869 · BAYER PHARMS
- 2025NIMODIPINEGeneric (ANDA)
ANDA 213409 · ALKEM LABS LTD
- 2024NIMODIPINEGeneric (ANDA)
ANDA 216937 · ANNORA PHARMA
- 2015NIMODIPINEGeneric (ANDA)
ANDA 201832 · SOFGEN PHARMS
- 2008NIMODIPINEGeneric (ANDA)
ANDA 076740 · BIONPHARMA
- 2007NIMODIPINEGeneric (ANDA)
ANDA 077811 · HERITAGE
- 2007NIMODIPINEGeneric (ANDA)
ANDA 077067 · SUN PHARM INDS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
